SMIVET

Smivet email format

Verified email-pattern data for Smivet is currently limited. You can still use the company insights and contact sections below.
Smivet is a veterinary biotech company focused on developing biotherapeutics to treat diseased animals. The single-domain antibody (SDA) technology is best suited to pursue this purpose. The SDA technology was discovered in the 1990’s in Belgium and further developed for human medicine. Smivet has translated and adapted the technology to make it fit for purpose for animal health. The SDA technology provides better developability traits for multiple species products compared to alternative species-specific platforms. The attractiveness of SMIVET’s SDA platform for Serum Half-Life Extension (SHLE) is the use of a single SHLE SDA across multiple species without major adaptations (Harmsen, Ackerschott and De Smit, 2024). By doing so we overcome the need to pursue species specific products as required for other platforms. Applications Potential product areas are both infectious disease targets and non-infectious chronic disease targets. The first product to be delivered is an SDA that neutralizes a deadly bacterial toxin (De Smit et al. 2021).
Looking for a particular SMIVET employee's phone or email?

Smivet Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant